000 01238nas  2200277za 4500
0019.507530
003CaOODSP
00520210614153444
007cr |||||||||||
008150406d20122019oncqr p o||||f0   a0eng|d
022 |a2561-5572
040 |aCaOODSP|beng
043 |an-cn---
0861 |aH2-2E-PDF
222 0|aDrug submission performance quarterly report ... |b(Canada. Biologics and Genetic Therapies Directorate)
24500|aDrug submission performance quarterly report ... |h[electronic resource] / |cBiologics and Genetic Therapies Directorate.
24637|aBGTD quarterly drug submission performance report
260 |aOttawa : |bHealth Canada, |c2012-2019.
310 |aQuarterly
3621 |aBegan with: Jan.-Mar. 2012; suspended with July-Sept. 2012; resumed with Oct.-Dec. 2017; ceased with Oct.-Dec. 2019.
500 |aIssued also in French under title: Rapport trimestriel du rendement des présentations de drogue...
516 |aElectronic serial in PDF format.
69207|2gccst|aDrugs
7101 |aCanada. |bHealth Canada.
77508|tRapport trimestriel du rendement des présentations de drogue ... |w(CaOODSP)9.503920
78500|tDrug submission performance quarterly report / |w(CaOODSP)9.893870